Avalon GloboCare
Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial-stage micro-cap operating in Consumer Health (FDA-registered KetoAir breathalyzer) and Agentic AI (Catch-Up video content platform), serving ketogenic diet consumers, wellness programs, and digital content creators.
- Company typePublic
- Founded2015
- HeadquartersFreehold, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Avalon GloboCare does
Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial-stage micro-cap company headquartered in Freehold, New Jersey, operating two business segments: Consumer Health and Agentic AI. Founded in 2015 and incorporated in Delaware, the company employs 1 to 10 staff and carries a market capitalization ranging from approximately $2.53 million to $5.7 million across late 2025 and early 2026. The company's strategic positioning shifted materially with the December 2025 acquisition of RPM Interactive, which was merged into a newly formed subsidiary, Avalon Quantum AI LLC, reorienting the business around AI-enabled digital content and consumer health.
The product portfolio spans three pillars. The Consumer Health segment is anchored by the KetoAir handheld breathalyzer, an FDA-registered Class I medical device (registration number 3026284320) using nanosensor technology to non-invasively measure ketosis levels for ketogenic diet management, athletic performance, and therapeutic ketogenic programs; the device is sold via B2B and B2C channels in North America with planned Q2 2026 launch. The Agentic AI segment centers on Catch-Up, a SaaS platform acquired via RPM Interactive that automates the creation and distribution of short-form video, audio, and digital media content for social media influencers, podcasters, and digital content creators, currently undergoing Phase 2 development with Caylent and AWS to convert it into a fully autonomous agentic AI system. The company also maintains joint intellectual property with the Massachusetts Institute of Technology for the QTY protein design platform supporting precision diagnostics development.
Avalon GloboCare generates revenue through SaaS platform licensing for Catch-Up, hardware sales of KetoAir devices, and AI-powered marketing services leveraging the Catch-Up platform for consumer health products. The company reported 119% revenue growth over the trailing twelve months but continues to operate at a loss with negative EBITDA of $6.9 million and negative stockholders' equity of $3.9 million, triggering a Nasdaq non-compliance notice. The balance sheet has been reinforced through the $19.5 million RPM Interactive all-stock acquisition and a February 2026 private placement of approximately $3.25 million led by H.C. Wainwright & Co. and Roth Capital Partners, with up to $6.5 million of additional proceeds contingent on warrant exercises. The company has also announced a proposed merger with YOOV Group Holding Limited.
Avalon GloboCare firmographics
Firmographics- Name
- Avalon GloboCare
- Legal name
- Avalon GloboCare Corp.
- Website
- https://avalon-globocare.com
- Company type
- Public
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial-stage micro-cap operating in Consumer Health (FDA-registered KetoAir breathalyzer) and Agentic AI (Catch-Up video content platform), serving ketogenic diet consumers, wellness programs, and digital content creators.
- Ownership category
- akta.pro rank
Avalon GloboCare industry classification
Industry- Product category
- AI Video Generation Software
- NAICS
- Software Publishers (5132), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), AI/ML Engineering & Model Development Services (BPAEAHAF)
Keywords
Where Avalon GloboCare is headquartered
LocationHeadquarters
- HQ city
- Freehold
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Avalon GloboCare business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- SaaS Platform Licensing: Catch-Up agentic AI video platform licensed to content creators, media companies, and brands on a subscription or usage basis for automated video content generation and distribution.
- KetoAir Device Sales: Sale of KetoAir handheld breathalyzer devices for ketogenic health management targeting B2B and B2C markets in North America.
- AI-Powered Marketing Services: Leveraging Catch-Up AI platform to support marketing efforts for consumer health products like KetoAir, enabling digital engagement and content-driven monetization.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Avalon GloboCare product offering
Product offeringCore offering
Avalon GloboCare commercially delivers the Catch-Up agentic AI SaaS video-generation platform (via subsidiary Avalon Quantum AI LLC) for automated short-form video and digital content creation, and the KetoAir FDA-registered Class I medical breathalyzer device that non-invasively measures ketosis using nanosensor technology for ketogenic health management. The company also holds joint IP with MIT for the QTY protein design platform supporting precision diagnostics research.
Product overview
Avalon GloboCare operates as a commercial-stage company with two core business segments: Consumer Health and Agentic AI Technology. The Consumer Health segment centers on the KetoAir breathalyzer device (FDA-registered Class I medical device) that measures ketosis levels using proprietary nanosensor technology. The Agentic AI segment is anchored by the Catch-Up platform, an AI-powered SaaS product acquired through the December 2025 purchase of RPM Interactive. The Catch-Up platform transforms from a manually-configured AI video production system into a fully autonomous, agentic AI-driven video platform enabling social media influencers and digital content creators to generate personalized video content at scale. The company also holds joint intellectual property with MIT for the QTY protein design platform. The AI and consumer health divisions are designed to complement each other, with the Catch-Up platform being used to support marketing for KetoAir and other consumer health products.
Differentiator
Problem solved
Functional benefit
Brands
- KetoAir: FDA-registered Class I medical device breathalyzer that measures ketosis levels using nanosensor technology, sold in North America for ketogenic health management.
- Catch-Up
- Avalon Quantum AI
Products and services
- Catch-Up Agentic AI Video Platform The Catch-Up platform is an agentic AI-powered SaaS solution that automates the creation and distribution of short-form video and digital media content at scale. It enables social media influencers, podcasters, and digital content creators to generate personalized video content across multiple platforms with minimal technical expertise, and serves brands and media companies as enterprise customers seeking AI-powered video content generation and digital marketing automation.
- KetoAir Breathalyzer Device KetoAir is a non-invasive handheld breathalyzer device that measures ketosis levels using proprietary nanosensor technology. It is registered with the U.S. Food and Drug Administration as a Class I medical device (registration number 3026284320), maintained under Qi Diagnostics Limited, and is sold in North America to health-conscious consumers following ketogenic diets for weight management, athletic performance, and therapeutic programs, as well as to organizations and government wellness programs (e.g., the Nevada POOL/PACT first responder program).
Quantifiable outcome
- 66% average participant engagement rate in Nevada first responder wellness program
- +1 more outcomes
Companies that use Avalon GloboCare
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
Avalon GloboCare technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature4 records
Avalon GloboCare partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Caylent, Inc.coreCaylent, an AWS Premier Tier Consulting Partner, was appointed to lead Phase 2 development of the Catch-Up platform. The collaboration aims to transform the platform from a manually configured AI video production system into a fully autonomous, agentic AI-driven video platform. Caylent has been recognized as AWS Migration Consulting Partner of the Year, GenAI Industry Solution Partner of the Year, and Application Modernization Partner of the Year.
- Amazon Web Services (AWS)coreAWS collaboration supporting Phase 2 development of the Catch-Up agentic AI video platform. AWS provides the cloud infrastructure foundation for the platform's transition into a fully autonomous system enabling non-technical content creators to generate personalized video content across social media platforms.
- Advanced Micro Devices (AMD)coreAvalon Quantum AI LLC was accepted into the AMD AI Developer Program, gaining access to AMD Developer Cloud credits, advanced tools, training, and high-performance compute resources powered by AMD Instinct accelerators and EPYC processors. This partnership is intended to accelerate automated commentary video generation, enterprise documentation tools, and AI-powered workflow automation.
- Saga Health and SpecialtyHealth, Inc.minorCollaboration for the Nevada POOL/PACT Holistic Health Reset program, a four-month wellness initiative launched August 2025 designed to support 50 first responders using Avalon's KetoAir breath-based metabolic monitoring technology. Mid-program data demonstrated improvements in metabolic health metrics among participants.
- Qi Diagnostics LimitedminorMemorandum of understanding for proposed co-development of a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. The MOU provided Avalon with a 120-day exclusivity period to negotiate a definitive agreement for initial prototype-enabling stage involving critical research, data collection, software development, and prototype design.
- YOOV Group Holding LimitedminorProposed merger with YOOV Group Holding Limited, for which relevant materials have been filed with the SEC. This represents a potential strategic transaction for the company.
- Massachusetts Institute of Technology (MIT)coreJoint intellectual property arrangement for QTY protein design platform, representing a strategic research partnership for precision diagnostics development.
Scale indicators8 records
Recent moves8 records
Expansion highlights5 records
Avalon GloboCare competitors and assessment
Company assessmentDirect peers
- Descript: Descript provides AI-powered video and audio editing tools aimed at podcasters and content creators. Its automation of editing workflows parallels Catch-Up's agentic approach to short-form video production.
- HeyGen: HeyGen offers an AI video generation platform with avatars and multilingual video creation capabilities for marketing, sales, and content teams. It competes in the same AI-driven video automation space as Catch-Up.
- Pika Labs: Pika Labs develops generative AI video tools that enable creators to produce and edit short-form video content from text prompts. Its focus on accessible AI video generation aligns closely with Catch-Up's target user base.
- Synthesia: Synthesia provides AI-generated video with avatars for enterprise training, marketing, and content creation. It is a direct competitor in automated AI video production targeting business and creator use cases.
- InVideo: InVideo offers an AI-driven video creation platform with templates and automation targeted at marketers and creators. It overlaps with Catch-Up on scalable AI video production for digital content.
- Runway: Runway is a leading AI video generation platform used by content creators, filmmakers, and brands to produce video from text and image prompts. It directly competes with Catch-Up in the agentic AI short-form video creation category.
Broad incumbents
- Canva (Magic Studio): Canva's Magic Studio integrates AI video and design tools within a broad creative platform used by creators and businesses. It competes with Catch-Up on AI-assisted content creation but offers a much wider portfolio of design and collaboration tools.
- Bio-Techne: Bio-Techne provides reagents, assays, and proteomic research tools widely used in life science research. It is broadly comparable to Avalon's biotech diagnostics ambitions (QTY protein design platform) as a larger incumbent in protein-related life sciences.
Emerging players
- Lumen Health: Lumen is a handheld breath-based metabolic tracker that measures fat metabolism via breath acetone. It is a direct adjacent peer to KetoAir's non-invasive breath-based ketosis monitoring approach for ketogenic diet and metabolic wellness users.
- Levels Health: Levels Health offers a continuous glucose monitor paired with software for metabolic health tracking. It is comparable to Avalon's KetoAir as a consumer-facing metabolic monitoring product targeting wellness-oriented users.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Avalon GloboCare social profiles
Digital presenceAvalon GloboCare compliance and trust
Trust signalCompliance1 record
Avalon GloboCare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avalon GloboCare leadership team
Management profileNumber of profiles
Profiles8 records
Avalon GloboCare subsidiaries and ownership
Company hierarchySubsidiaries1 record
Avalon GloboCare funding detail
Funding detailFunding overview
Funding rounds3 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avalon GloboCare M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avalon GloboCare
What does Avalon GloboCare do?
Avalon GloboCare commercially delivers the Catch-Up agentic AI SaaS video-generation platform (via subsidiary Avalon Quantum AI LLC) for automated short-form video and digital content creation, and the KetoAir FDA-registered Class I medical breathalyzer device that non-invasively measures ketosis using nanosensor technology for ketogenic health management. The company also holds joint IP with MIT for the QTY protein design platform supporting precision diagnostics research.
Is Avalon GloboCare a public or private company?
Avalon GloboCare is a public company. It is classified as public and is currently operating.
When was Avalon GloboCare founded?
Avalon GloboCare was founded in 2015. It employs 1 to 10 people.
Where is Avalon GloboCare based?
Avalon GloboCare is headquartered in Freehold, United States, in the North America region.
How does Avalon GloboCare make money?
Three revenue lines are on record. SaaS Platform Licensing is the primary driver. The others are ketoAir Device Sales and AI-Powered Marketing Services.
Who are Avalon GloboCare's main competitors?
Direct peers on record are Descript, HeyGen, Pika Labs, Synthesia, InVideo and Runway. Broad incumbents are Canva (Magic Studio) and Bio-Techne. Emerging players are Lumen Health and Levels Health.
Does Avalon GloboCare have an API?
No public API is recorded for Avalon GloboCare.
What industry is Avalon GloboCare in?
Avalon GloboCare's product category is AI Video Generation Software. Its primary akta.pro industry code is HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management), with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5132 and its SIC code is 3845.